CAS RN: 954137-48-5
5-Bromo-7,7-dimethyl-7H-benzo[c]fluorene
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250916
1g / 5g / 25g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 954137-48-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
>97%
0
Out of Stock
Beijing
Inquiry
954137-48-5 / 5-bromo-7,7-dimethylbenzo[c]fluorene
Standard CAS: 954137-48-5
Multi CAS: No
Basic Information
copy
CAS
954137-48-5 copy
Multi CAS
No copy
Molecular Formula
C19H15BR copy
Molecular Weight
323.200000 copy
Exact Mass
322.035710 copy
InChI
InChI=1S/C19H15Br/c1-19(2)15-10-6-5-9-14(15)18-13-8-4-3-7-12(13)17(20)11-16(18)19/h3-11H,1-2H3 copy
InChIKey
KCHRZPPNAWBDQZ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
20 copy
Aromatic heavy atom count
16 copy
Fraction Csp3
0.16 copy
Molar refractivity
89.21 copy
TPSA
0.0000 copy
LogP / Solubility
WLOGP
5.91 copy
MLOGP
5.21 copy
XLogP3
6.4 copy
Consensus LogP
5.84 copy
Log S (ESOL)
-6.16 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-6.48 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-6.67 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-0.5 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy